[1] |
Ingram JR. The genetics of hidradenitis suppurativa[J]. Dermatol Clin, 2016,34(1):23⁃28. doi: 10.1016/j.det.2015.07.002.
|
[2] |
Wang B, Yang W, Wen W, et al. Gamma⁃secretase gene mutations in familial acne inversa[J]. Science, 2010,330(6007):1065. doi: 10.1126/science.1196284.
|
[3] |
Li C, Li W, Xu H, et al. PSENEN mutation carriers with co⁃manifestation of acne inversa (AI) and Dowling⁃Degos disease (DDD): is AI or DDD the subphenotype?[J]. J Invest Dermatol, 2017,137(10):2234⁃2236. doi: 10.1016/j.jid.2017.05.021.
|
[4] |
Pink A, Anzengruber F, Navarini AA. Acne and hidradenitis suppurativa[J]. Br J Dermatol, 2018,178(3):619⁃631. doi: 10. 1111/bjd.16231.
|
[5] |
Carroll CM, Li YM. Physiological and pathological roles of the γ⁃secretase complex[J]. Brain Res Bull, 2016,126(Pt 2):199⁃206. doi: 10.1016/j.brainresbull.2016.04.019.
|
[6] |
ARJV V, van der Zee HH, Prens EP. Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms[J]. Br J Dermatol, 2017,177(4):895⁃896. doi: 10. 1111/bjd.15812.
|
[7] |
Xiao X, He Y, Li C, et al. Nicastrin mutations in familial acne inversa impact keratinocyte proliferation and differentiation through the Notch and phosphoinositide 3⁃kinase AKT signalling pathways[J]. Br J Dermatol, 2016,174(3):522⁃532. doi: 10.1111/ bjd.14223.
|
[8] |
Pink AE, Dafou D, Desai N, et al. Hidradenitis suppurativa: haploinsufficiency of gamma⁃secretase components does not affect gamma⁃secretase enzyme activity in vitro[J]. Br J Dermatol, 2016,175(3):632⁃635. doi: 10.1111/bjd.14621.
|
[9] |
Zhang X, Sisodia SS. Acne inversa caused by missense mutations in NCSTN is not fully compatible with impairments in Notch signaling[J]. J Invest Dermatol, 2015,135(2):618⁃620. doi: 10. 1038/jid.2014.399.
|
[10] |
JAM M, Ojala VK, Knittle AM, et al. Genome⁃wide screen of gamma⁃secretase⁃mediated intramembrane cleavage of receptor tyrosine kinases[J]. Mol Biol Cell, 2017,28(22):3123⁃3131. doi: 10.1091/mbc.e17⁃04⁃0261.
|
[11] |
Savva A, Kanni T, Damoraki G, et al. Impact of Toll⁃like receptor⁃4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa[J]. Br J Dermatol, 2013,168(2):311⁃317. doi: 10.1111/bjd.12105.
|
[12] |
Ingram JR, Wood M, John B, et al. Absence of pathogenic γ⁃secretase mutations in a South Wales cohort of familial and sporadic hidradenitis suppurativa (acne inversa)[J]. Br J Dermatol, 2013,168(4):874⁃876. doi: 10.1111/bjd.2013.168.issue⁃4.
|
[13] |
Fitzsimmons JS, Guilbert PR, Fitzsimmons EM. Evidence of genetic factors in hidradenitis suppurativa[J]. Br J Dermatol, 1985,113(1):1⁃8.
|
[14] |
肖学敏, 李诚让, 何艳艳, 等. Nicastrin基因突变的反常性痤疮患者皮损Notch⁃HES信号通路的表达[J]. 中华皮肤科杂志, 2016,49(6):415⁃419. doi: 10.3760/cma.j.issn.0412⁃4030. 2016.06.012.
|
[15] |
Melnik BC, Plewig G. Impaired Notch⁃MKP⁃1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology[J]. Exp Dermatol, 2013,22(3):172⁃177. doi: 10.1111/exd.12098.
|
[16] |
Melnik BC, John SM, Chen W, et al. T helper 17 cellregulatory T⁃cell imbalance in hidradenitis suppurativaacne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities[J]. Br J Dermatol, 2018,179(2):260⁃272. doi: 10.1111/bjd.2018.179.issue⁃6.
|
[17] |
Jurisch⁃Yaksi N, Sannerud R, Annaert W. A fast growing spectrum of biological functions of gamma⁃secretase in development and disease[J]. Biochim Biophys Acta, 2013,1828(12):2815⁃2827. doi: 10.1016/j.bbamem.2013.04.016.
|
[18] |
Duchatelet S, Miskinyte S, Join⁃Lambert O, et al. First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome[J]. Br J Dermatol, 2015,173(2):610⁃612. doi: 10.1111/bjd.13668.
|
[19] |
Garg A, Strunk A. Risk of Alzheimer′s disease is not increased among patients with hidradenitis suppurativa: a retrospective population⁃based cohort analysis[J]. J Am Acad Dermatol, 2017,77(1):176⁃177. doi: 10.1016/j.jaad.2017.02.055.
|
[20] |
Panmontha W, Rerknimitr P, Yeetong P, et al. A frameshift mutation in PEN⁃2 causes familial comedones syndrome[J]. Dermatology, 2015,231(1):77⁃81. doi: 10.1159/000382122.
|
[21] |
Deckers IE, van der Zee HH, Boer J, et al. Correlation of early⁃onset hidradenitis suppurativa with stronger genetic suscepti⁃bility and more widespread involvement[J]. J Am Acad Dermatol, 2015,72(3):485⁃488. doi: 10.1016/j.jaad.2014.11.017.
|
[22] |
Canoui⁃Poitrine F, Le Thuaut A, Revuz JE, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross⁃sectional study[J]. J Invest Dermatol, 2013,133(6):1506⁃1511. doi: 10.1038/jid.2012.472.
|
[23] |
Ingram JR, Piguet V. Phenotypic heterogeneity in hidradenitis suppurativa (acne inversa): classification is an essential step toward personalized therapy[J]. J Invest Dermatol, 2013,133(6):1453⁃1456. doi: 10.1038/jid.2012.476.
|
[24] |
Xu H, Xiao X, Hui Y, et al. Phenotype of 53 Chinese individuals with nicastrin gene mutations in association with familial hidradenitis suppurativa (acne inversa)[J]. Br J Dermatol, 2016,174(4):927⁃929. doi: 10.1111/bjd.2016.174.issue⁃4.
|